ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
$142.6 million cash and cash equivalents and marketable securities as of September ...
Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer ( SITC 2025 ) - Replimune Group ( NASDAQ:REPL )
WOBURN, Mass., Nov. 07, 2025 ( GLOBE NEWSWIRE ) -- Replimune Group, Inc. ( NASDAQ:REPL ) , a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that biomarker data and updated clinical data from the IGNYTE clinical trial of RP1 ...
Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer ( SITC 2025 )
Oral presentation of biomarker data shows RP1 plus nivolumab reverses multiple resistance mechanisms to PD-1 blockade in advanced melanoma following definitive anti-PD-1 failure Oral presentation of biomarker data shows RP1 plus nivolumab reverses multiple resistance mechanisms to PD-1 blockade ...
Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session - ALPS Group ( NASDAQ:ALPS ) , Alvotech ( NASDAQ:ALVO )
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining more than 100 points on Monday. Shares of Kimberly-Clark Corporation ( NYSE:KMB ) fell sharply in pre-market trading after the company announced it will acquire Kenvue in a cash and stock transaction with an enterprise ...
This Five Below Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Five Below ( NASDAQ:FIVE ) , Booking Holdings ( NASDAQ:BKNG )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Why Replimune Stock Was Soaring Today
An investigational treatment, used in combination with another cancer medication, took an important step forward after several setbacks.
WW International, Replimune Group, Datavault AI, GRAIL And Other Big Stocks Moving Higher On Monday - American Battery Tech ( NASDAQ:ABAT ) , Amazon.com ( NASDAQ:AMZN )
U.S. stocks were higher, with the Nasdaq Composite gaining more than 1% on Monday. Shares of WW International, Inc. ( NASDAQ:WW ) rose sharply during Monday's session after announcing a partnership with Amazon.com, Inc.'s ( NASDAQ:AMZN ) Amazon Pharmacy to make weight management medications ...
Dow Jumps Over 200 Points; Cleveland-Cliffs Shares Jump After Q3 Results - Celcuity ( NASDAQ:CELC ) , Adaptimmune Therapeutics ( NASDAQ:ADAP )
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. Following the market opening Tuesday, the Dow traded up 0.47% to 46,407.15 while the NASDAQ gained 0.93% to 22,890.22. The S&P 500 also rose, gaining, 0.61% to 6,704.61.
Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025
WOBURN, Mass., Oct. 19, 2025 ( GLOBE NEWSWIRE ) -- Replimune Group, Inc. ( NASDAQ: REPL ) , a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced data from a new ad hoc analysis from the IGNYTE phase 2 cohort of RP1 plus nivolumab ...
REPLIMUNE ALERT: Bragar Eagel & Squire, P.C. is Investigating Replimune Group, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm - Replimune Group ( NASDAQ:REPL )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Replimune ( REPL ) To Contact Him Directly To Discuss Their Options
REPL Stock Plunges 54% in 3 Months After FDA Rejects Skin Cancer Drug
Replimune stock dives 54% over three months after the FDA rejects its RP1/Opdivo melanoma drug filing, delaying its first potential product launch.
REPLIMUNE FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Replimune Group, Inc. Investors to Contact the Firm Regarding Class Action Lawsuit - Replimune Group ( NASDAQ:REPL )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Replimune ( REPL ) To Contact Him Directly To Discuss Their Options
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - Replimune Group ( NASDAQ:REPL )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Replimune To Contact Him Directly To Discuss Their Options
REPL DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class...
New York, New York-- ( Newsfile Corp. - September 21, 2025 ) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. ( NASDAQ: REPL ) between November 22, 2024 and July 21, 2025, both dates inclusive ( the "Class Period" ) , of the ...
REPL DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Sept. 21, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
Class Action Filed Against Replimune Group, Inc. ( REPL ) Seeking Recovery for Investors - Contact Levi & Korsinsky - Replimune Group ( NASDAQ:REPL )
NEW YORK, Sept. 19, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ( "Replimune Group, Inc." or the "Company" ) REPL of a class action securities lawsuit.
Why Replimune Stock Was Tumbling Again Today
The biotech's recent meeting with FDA officials continued to resonate.
REPL 3-DAY DEADLINE ALERT: Replimune ( REPL ) Shares Tank 45% After Company Says No Pathway Identified For Lead Drug RP1, Securities Class Action Pending - Hagens Berman - Replimune Group ( NASDAQ:REPL )
SAN FRANCISCO, Sept. 19, 2025 ( GLOBE NEWSWIRE ) -- On September 18, 2025, investors in Replimune Group, Inc. ( NASDAQ:REPL ) saw the price of their shares crater about 45% during intraday trading after the company announced that it completed a Type A meeting with the FDA on September 16 to ...
This United Parcel Service Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday - 89bio ( NASDAQ:ETNB ) , Replimune Group ( NASDAQ:REPL )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BMO Capital analyst Fadi Chamoun downgraded United Parcel Service, Inc.
Why Replimune Stock Plummeted by Almost 40% Today
The fate of a once-promising cancer treatment now looks uncertain at best.
Gold Falls Over 1%; Darden Posts Downbeat Earnings - BioCardia ( NASDAQ:BCDA ) , Aptevo Therapeutics ( NASDAQ:APVO )
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 150 points on Thursday. The Dow traded up 0.37% to 46,190.85 while the NASDAQ rose 1.07% to 22,500.28. The S&P 500 also rose, gaining, 0.62% to 6,641.29. Information technology shares jumped by 0.8% on ...
Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge - Aptevo Therapeutics ( NASDAQ:APVO ) , Aeries Technology ( NASDAQ:AERT )
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Thursday. Following the market opening Thursday, the Dow traded down 0.04% to 46,000.59 while the NASDAQ rose 0.49% to 22,370.12. The S&P 500 also rose, gaining, 0.29% to 6,619.34.
Replimune Provides Update Following Type A Meeting with FDA
WOBURN, Mass., Sept. 18, 2025 ( GLOBE NEWSWIRE ) -- Replimune Group, Inc. ( NASDAQ: REPL ) , a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that the company completed a Type A meeting with the U.S.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - Replimune Group ( NASDAQ:REPL )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Replimune To Contact Him Directly To Discuss Their Options
Levi & Korsinsky Notifies Replimune Group, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Sept. 16, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ( "Replimune Group, Inc." or the "Company" ) REPL of a class action securities lawsuit.
Replimune Group, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 22, 2025 Deadline to file Lead Plaintiff Motion. - Replimune Group ( NASDAQ:REPL )
Investors can contact the law firm at no cost to learn more about recovering their losses
REPL DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important September 22 Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Sept. 15, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
Contact The Gross Law Firm by September 22, 2025 Deadline to Join Class Action Against Replimune Group, Inc. ( REPL ) - Replimune Group ( NASDAQ:REPL )
NEW YORK, Sept. 15, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Replimune Group, Inc. REPL. Shareholders who purchased shares of REPL during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - Replimune Group ( NASDAQ:REPL )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Replimune To Contact Him Directly To Discuss Their Options
Levi & Korsinsky Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Sept. 11, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ( "Replimune Group, Inc." or the "Company" ) REPL of a class action securities lawsuit.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Sept. 10, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc. ( "Replimune" or the "Company" ) REPL. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ( or 888.4-POMLAW ...
REPL DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
REPL 2-WEEK DEADLINE ALERT: Replimune ( REPL ) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval - Hagens Berman - Replimune Group ( NASDAQ:REPL )
SAN FRANCISCO, Sept. 08, 2025 ( GLOBE NEWSWIRE ) -- Replimune Group Inc. REPL is under fire from investors following a dramatic regulatory setback that sent its stock into freefall.
Faruqi & Faruqi Reminds Replimune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPL - Replimune Group ( NASDAQ:REPL )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Replimune To Contact Him Directly To Discuss Their Options
Replimune Group, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 22, 2025 Deadline to file Lead Plaintiff Motion. - Replimune Group ( NASDAQ:REPL )
Investors can contact the law firm at no cost to learn more about recovering their losses
REPL DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Sept. 05, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
Replimune ( REPL ) Faces Investor Lawsuit After FDA Blocks Cancer Drug Approval - Hagens Berman - Replimune Group ( NASDAQ:REPL )
SAN FRANCISCO, Sept. 05, 2025 ( GLOBE NEWSWIRE ) -- Replimune Group Inc. REPL is under fire from investors following a dramatic regulatory setback that sent its stock into freefall.
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - Replimune Group ( NASDAQ:REPL )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Replimune To Contact Him Directly To Discuss Their Options
Shareholders that lost money on Replimune Group, Inc. ( REPL ) should contact Levi & Korsinsky about pending Class Action - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Sept. 02, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ( "Replimune Group, Inc." or the "Company" ) REPL of a class action securities lawsuit.
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Sept. 01, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
ROSEN, A LONGSTANDING FIRM, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL
New York, New York-- ( Newsfile Corp. - August 30, 2025 ) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. ( NASDAQ: REPL ) between November 22, 2024 and July 21, 2025, both dates inclusive ( the "Class Period" ) , of the ...
REPL Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Replimune Group, Inc. ( REPL ) Investors that a Securities Fraud Class Action Lawsuit Has Been Filed - Replimune Group ( NASDAQ:REPL )
RADNOR, Pa., Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) informs investors that a securities class action lawsuit has been filed against Replimune Group, Inc. ( "Replimune" ) REPL on behalf of those who purchased or otherwise acquired ...
ROSEN, A TOP RANKED LAW FIRM, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 28, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune - Replimune Group ( NASDAQ:REPL )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Replimune To Contact Him Directly To Discuss Their Options
REPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 28, 2025 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Replimune Group, Inc. ( "Replimune" or "the Company" ) REPL and certain of its ...
Kirby McInerney LLP Reminds Replimune Group, Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 27, 2025 ( GLOBE NEWSWIRE ) -- Kirby McInerney LLP reminds investors who purchased Replimune Group, Inc. ( "Replimune" or the "Company" ) REPL securities to contact Thomas W.
Investors who lost money on Replimune Group, Inc. ( REPL ) should contact Levi & Korsinsky about pending Class Action - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Replimune Group, Inc. ( "Replimune Group, Inc." or the "Company" ) REPL of a class action securities lawsuit.
Replimune ( REPL ) Faces Investor Lawsuit Following 77% Stock Crash After FDA Rejects Key Drug - Hagens Berman - Replimune Group ( NASDAQ:REPL )
SAN FRANCISCO, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Hagens Berman is investigating claims alleged in a new securities class action against Replimune Group, Inc.
ROSEN, THE FIRST FILING FIRM, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL - Replimune Group ( NASDAQ:REPL )
NEW YORK, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP announces that a class action lawsuit has been filed against Replimune Group, Inc. ( "Replimune" or the "Company" ) REPL. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ( or 888.4-POMLAW ) ...
